dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Kutse

Sotsiaalministeerium · 3. oktoober 2018
Viit
1.4-4/3093-1
Registreeritud
3. oktoober 2018
Dokumendi liik
Sissetulev kiri
Adressaat
Embassy of Belarus
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2018
Vastutaja
Gerda Mälk (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Ravimiosakond)
Lahendamise tähtaeg
18. oktoober 2018

Failid

  • 📎Agenda_20-22 Nov_ENG_18.pdf505 KB
  • 📎IMG_20181003_0001.pdf1647 KB
  • 📎letter from the embassy of Belarus.msg1717 KB
  • 📎Minsk2_Concept Note_15Aug_Eng.pdf701 KB
  • 📎Valgevenes Minskis korraldavast ravimialasest konsultatsioonidest 20-22-11.2018.msg1721 KB

Sisu (failidest)

Saatja: Vivian Saarpere <[email protected]> Saaja: SM Info Teema: Valgevenes, Minskis korraldavast ravimialasest konsultatsioonidest 20-22-11.2018 Tere Edastame tervishoiu ja töövaldkonna suunale Eesti saatkonnale Minskis edastatud informatsiooni Minskis 20-22. novembril toimuvatele ravimialasele konsultatsioonidele. Palume teie kaasabi selle info edastamisel asjast huvitatud instantsidele. Lugupidamisega Vivian Saarpere Mobiil +375445906911 E-post [email protected]<mailto:[email protected]> Telefon +375172177061 EV suursaatkond Minskis [email protected]<mailto:[email protected]> koduleht: http:// www.estemb.by/ Välisministeeriumi koduleht: http://www.vm.ee/ Eastern Europe and Central Asia (EECA) Second Regional Consultation on Expanding Access to Affordable and Quality Assured Medicines and Diagnostic Technologies Date: 20-22 November 2018 Venue: Marriott Hotel Minsk, Pobediteley ave., 20, “Falcon” conference hall Tentative Agenda Day 1, 20 November 08:30 – 09:00 Registration of participants Conference floor lobby 09:00 – 09:15 Welcoming remarks Belarus Minister of Health (TBC) UN Resident Coordinator in Belarus Objectives of the meeting UNAIDS SESSION I: Alignment of national guidelines as a way to increase access to quality affordable medicines and diagnostic technology Chair, facilitator: TBC 09:15– 09:30 HIV treatment optimisation and acceleration of WHO/Europe Test & Treat strategy 09:30 - 09:45 Simplified treatment of HCV and use of WHO Europe or WHO HQ pangenotypic regimens 09:45 -10:00 Roll out of new TB medicines Stop TB Partnership/Global Drug Facility 10:00 -10:20 HIV, TB and viral hepatitis diagnostic technology UNITAID landscape (including polyvalent testing platforms) 10:20 -10:35 Q&As 10:35-11:05 Coffee Break SESSION II: Using the regulatory framework as a way to increase access to quality affordable drugs Chair, facilitator: TBC 11:05 - 11:20 Overview of legal and regulatory frameworks ITPCru for antiretroviral and viral hepatitis treatment in Eastern Europe and Central Asia 11:20 – 11:35 Regulatory environment for TB medicines in Stop TB Partnership Eastern Europe and Central Asia 11:35 - 11:50 Public health-oriented licensing Esteban Burrone (TBC), Medicines Patent Pool 11:50 – 12:20 Collaborative Registration: key principles and WHO EURO, processes Dr Olexandr Polishchuk Price comparison of first line anti-TB medicines 12:20 – 13:20 Country examples for fast-tracking registration or Belarus adjusting packaging regulations Uzbekistan Turkmenistan Armenia Azerbaijan 13:20 – 13:30 Q&As 13:30 – 14:30 Lunch SESSION III: Chair, facilitator: TBC 14:30 – 15:45 What can we learn from the last 3 years of UNICEF procurement experiences to inform strategic procurement of ARVs to reach 90-90-90 in EECA? 15:45 – 16:00 MSF 16:00 – 16:10 Q&As SESSION IV: Access security to quality assured medicines Chair, facilitator: TBC 16:10 – 16:30 Overview of WHO Prequalification program WHO EURO, TB medicines in focus Dr Olexandr Polishchuk 16:30 – 17:00 Ukraine, Georgia: country case study on key MOH of Ukraine benefits and challenges of the registration through Petro Golodyuk (TBD) the WHO Collaborative Registration Process State Expert Centre Georgia Medicines regulatory agency 17:00 – 17:10 Q&As 17:10 - 17:30 Coffee Break National regulations 17:30 - 17:45 NRA assessment & Benchmarking: case study WHO EURO, Dorina Pirgari from EECA countries Consultant 17:45- 18:00 Q&As 1 18:00 – 18:30 Closeout remarks/summary of the day Representative of the Ministry of Health 19:30 Dinner/reception Day 2, 21 November 08:30 – 09:00 Registration of participants Conference floor lobby Session IV: Accessing international procurement mechanisms as a way to increase access to quality affordable drugs (challenges and opportunities) Chair, facilitator: TBC 09:00 – 10:10 Panel Discussion: Facilitator/s  Kazakhstan using (State procurements through UNICEF (ARV) and UNDP (HCV)  Georgia (State procurements through GF PR/wambo)  Belarus  Moldova  Turkmenistan using (State procurements through UNDP)  Ukraine (Amendment of legislation to allow international procurement)  Republic of Armenia (Amendment of legislation to allow international procurement) 10:10 – 10:30 Q&As 10:30 – 11:00 Panel Discussion: Facilitator/s Procurements after graduation from GF; Challenges with ensuring access to affordable quality TB and HIV medicines transitioning from GF  Estonia  Latvia  Lithuania  Poland  Kyrgyzstan  Tajikistan  Armenia  Moldova 11:15 - 11:30 Q&As 11:30 -12:00 Coffee Break 2 SESSION V: Moving forward: Regional plans/roadmap and coordination platform Chair: Ministry of Health of Belarus Facilitators: (someone to draft instructions) 12:00 - 13:30 Group work – 3 groups to work on the following Available Plenary hall + 3 small rooms topics (30 min per group) Flipcharts or whiteboards are needed 1. Regulatory environment 2. Drug registration The session will be facilitated by all partners 3. Price reduction, including TRIPS involved in the meeting 13:30 – 14:30 Lunch 14:30 – 16:00 Plenary discussion 16:00 - 16:30 Coffee Break Joint Statement on expanded access to affordable and quality assured medicines and diagnostic technologies in Eastern Europe and Central Asia 16:30-17:30 Presentation of draft Joint Statement on expanded Representative of the Ministry of Health access to affordable and quality assured medicines Facilitators and diagnostic technologies in EECA Plenary discussion -feedback, comments on the Statement 17:30 -18:00 Closeout remarks/summary of the day Representative of the Ministry of Health 19:00 Dinner Eastern Europe and Central Asia (EECA) Second Regional Consultation on Expanding Access to Affordable and Quality Assured Medicines and Diagnostic Technologies Date: 22 November 2018 Venue: Marriott Hotel Minsk, Pobediteley ave., 20, “Falcon” conference hall Tentative Agenda 07:45 – 08:30 Registration of participants 3 Conference floor lobby (second floor) Facilitator: Svetlana Borovskaya, UNAIDS Goodwill Ambassador in Belarus? 08:30 - 08:45 Welcoming remarks Minister of Health of Belarus 08:45 - 09:00 Address from Belarusian Government Vice-prime minister (TBC) 09:00-09:30 Welcoming remarks UNAIDS GF WHO Stop TB Partnership 09:30 – 09:40 Summary of the technical meeting Speaker TBC 09:40 - 10:20 Panel and plenary discussion: Panel: International support for sustainable access UNAIDS to affordable quality assured drugs and Global Fund advanced diagnostic technologies WHO EURO, Hans Kluge Stop TB, Lucica Ditiu UNICEF (Experience from working with countries that graduated from GAVI) 10:20 - 10:35 Presentation and adoption of the Joint Ministry of Health Statement on expanded access to affordable and quality assured medicines and diagnostic technologies in EECA 10:35 -10:50 Joint Statement signing ceremony Facilitator: Svetlana Borovskaya, UNAIDS Goodwill Ambassador in Belarus? 10:50-11:20 Coffee-break Press conference Facilitators: 11:20-11:35 Presentation: HIV, TB and Viral Hepatitis epidemics and Dr Mariângela Batista Galvão Simão, Assistant access to medicines in EECA in line with Director-General for Drug Access, Vaccines and Global Plans and key recommendations Pharmaceuticals TBC from the UN SG High Level Panel on Access to Medicines 11:35-12:35 Panel discussion: Opportunities, challenges People+, ITPCru, MSF, TB Europe coalition, and prospect for sustainable access to Eurasian Women's Network on AIDS, All- 4 affordable quality assured drugs and Ukrainian network of PLHIV diagnostic technologies – Patient and community perspectives 12:35-12:50 Q&As 12:50-13:50 Panel Discussion: MoH representatives of: Towards ending HIV, TB and viral hepatitis Republic of Azerbaijan as a public health threat: translating new Georgia momentum into concrete results Republic of Moldova (10’per country) Republic of Tajikistan Ukraine Republic of Uzbekistan 13:50 - 15:00 Group Photo Lunch Facilitators: 15:00 – 16:00 Panel Discussion: MoH representatives of: Towards ending HIV, TB and viral hepatitis Republic of Armenia as a public health threat: translating new Republic of Belarus momentum into concrete results (10’ per Republic of Kazakhstan country) Kyrgyz Republic Russian Federation Turkmenistan 16:00 - 16:30 Plenary discussion - to sum up all the key Moderator: outcomes from the meeting and give possibility to those who did not have special slot in the agenda to speak 16:30 - 17:00 Coffee Break 17:00 – 17:30 Closing remarks Ministry of Health of Belarus 20-22 November 2018. To arrange different booths in the lobby: TA booth, where countries can come and request a TA identified during the meeting, GDF booth, where countries can discuss the collaboration, UNICEF booth (the same as for GDF etc), Global fund booth (presenting Wamboo or pooled procurement mechanism), MSF booth, PFSCM, etc 5 ( -l]i {i/f .Ч.\ ll J ф t/"r'T<"r"rl,Xr- ф %rn-rr* in, t}w, 7<ч"rlrlr- ф Z r,t ** J\ъ СiЁ-& в /Sоэ The Embassy of the Republic of Веlаrus in the Republic of Estonia presents its compliments to the Ministry оf Social Affairs of the Republic of Estonia and has the honour to forward the invitation to the 2"d Regional Consultation оп Expanding Access to Affordable and Quality Assured medicines and diagnostic technologies. The Embassy avails itself of this opportunity to renew to the Ministry the assurances of its highest consideration. 3,2018 to the Ministry of Social Affairs of the Republic of Estonia Tallinn ъ \.I MINISTRY ОF HEALTH ОF ТНЕ REPUBLIC ffi МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ ОF BELARUS РЕСПУБЛИКИ БЕЛАРУСЬ 220048, Minslq 39 Myasnikova Srгеееt Ул.Мясникова, 39, 22004В, г.Минск Рhопе : +3 75 l 7 -?22-65 -47, Fм: +] 7 5 1 7-222 -46-2'1 Тел. +37517 Z22 65 47, факс +З7517 22? 462J http ;//m i п zdlav €o_y, Ьу/еп Е-mаi l : mzrЬ @Ье l cml Ьу htгп ://minzdral,,gov.b]zlrц E-maiI: mzrb(@beIcmt.by еl,а?аа/t tt j9 €//ёщ На Ns Ms. Riina Sikkut Minister of Health and Labour of the Republic of Estonia Ministry of Social Affairs Suur-Аmееrikа 1 |ап2 Tallinn, Estonia Dear Minister, Оп behalf of the organizers of the Еаstеrп Еurоре and СепtrаI Asia (ЕЕСА) Znd Regional Consultation оп Expanding Aocess to Affordable and Quality Assured medicines and diagnostic technologies it is mу hопоur to invite you to participate in this eyent whioh will Ье held in Minsk, Belarus, оп 20-22 November 20 1 8 . The Consultation is hosted Ьу the Ministry of Health of the Republic of Belarus with organizational suрроrt Ьу the Joint United Nations Рrоgrаmmе on HIV/AIDS (LINAIDS), the Global Fuпd to Fight AIDS, ТuЬеrсulоsis and Malaria, the World Health Organization and the Stop ТВ Раrtпеrshiр. Participants at the Regional СопsulИtiоп will include the Ministers of Health, medioines supply poiicy makers апd regulators оf рhаrгпасеutiсаl sector frоm the 12 ЕЕСА countries: Аrmепiа, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Fеdеrаtiоп, Tajikistan, Turkmenistan, Ukraine arrd Uzbekistan, representatives of Lithuania, Latvia and Estonia, representatives of the international organizations, key раrtпеrs, relevant experts, representatives of the pharmaceutical companies, intemational рrосчrеmепt agents and mеmЬеrs of civil socieý. We аrе delighted to invite you to represent уочr country at the Regional Consultation and соuпt оп уочr participation оп 22 NочеrпЬеr 2018 - the hiф_lечеl segment of the meeting. То present the experience of Poland in medicines supply policy and regulations of pharmaceutical sесtоr during the technical раrt of the consulИtion that will take рlасе оп20-21 NочеmЬеr we kindly request уоu to nominate а specialist responsible for these issues in the ministry. The drаft Concept note is enclosed for уочr iпfоrmаtiоп. All fuПhеr documents will Ье sent directly to уоu well iп аdчапсе. The offioial languages of the event will Ье Russian and English. We sincerely hope that you will Ье able to accept оur inviИtion and would Ье grateful to гесеiче уочr confirmation together with the паmе of nominated specialist Ьуl8 ОсtоЬеr 2018 to the Ministry of Health of the Republio of Belarus Ьу е-mаil; ооцfmiпsk@Ьеlсmt.Ьу, Fоr morе iпfогmаtiоп please contact LINAIDS Country office in Belarus чiа tel.: +375 |72202461 оr emai1: [email protected], We look forward to welcoming you to Minsk in November. Yоurs sincerely, Minister of Health оf the Republic of Belarus Иана Vаlеry Malashko E}{CL (1) Saatja: Embassy of Belarus <[email protected]> Saaja: SM Info Teema: Fwd: letter from the Embassy of the Republic of Belarus Dear ladies and gentlemen, I will be pleased for the information about the participation of the Estonian side in the 2nd Regional Consultation on Expanding Access to Affordable and Quality Assured medicines and diagnostic technologies. -- Best regards, Yury Bulavko Counsellor of the Embassy of Belarus tel + 372 651 55 00 fax + 372 655 80 01 -------- Перенаправленное сообщение -------- Тема: letter from the Embassy of the Republic of Belarus Дата: Wed, 3 Oct 2018 15:54:26 +0300 От: Embassy of Belarus <[email protected]><mailto:[email protected]> Кому: [email protected]<mailto:[email protected]> letter from the Embassy of the Republic of Belarus -- Best regards, Yury Bulavko Counsellor of the Embassy of Belarus tel + 372 651 55 00 fax + 372 655 80 01 Eastern Europe and Central Asia (EECA) Second Regional Consultation on Expanding Access to Affordable and Quality Assured Medicines and Diagnostic Technologies 20-22 November 2018 Minsk, Belarus Background The Eastern Europe and central Asia region remains home to the fastest growing HIV infection and the highest levels of multidrug resistant (MDR) TB in the world. The estimated 323 000 incident TB cases in the Region include 27 000 cases (8.4%) with HIV co-infection. The main contributor to the development of resistant TB is mal-treated susceptible TB. The Region represents almost 20% of the total global hepatitis C virus (HCV) antibody-positive population and account for the largest proportion of HIV-infected persons who have serological evidence of past or present HCV infection. Over the last ten years, the EECA region have made significant strides to increase the number of people who know their HIV, TB, and viral hepatitis status and receive treatment, however these have not translated into any significant increase in regional coverage, figuring itself among the lowest in the world. Expanding ART eligibility based on World Health Organization (WHO) new recommendations “test and treat” had significant cost implications for the HIV response in all countries of the region. Yet overall, the region continues to pay high prices for ARV therapy, while at the same time providing some of the lowest coverage of people on treatment. The EECA is also the most affected region by drug resistant TB, especially multidrug resistant TB globally with a huge economic impact due to the high cost of second line drugs regimens and big challenges in ensuring access and scale up – with just a very small fraction of people in need being currently diagnosed and treated. The uptake of the new Antituberculosis medicines and new regimens is extremely slow and with limited availability. The current WHO guidelines recommend offering curative treatment with Direct Acting Antivirals (DAAs) to all persons infected with HCV. The cost of DAAs decreased dramatically in the last few years, especially in countries where generic DAAs are available (in some countries the price of 3-months curative treatment course decreased 1000- fold comparing to the initial price for branded medicines), and many countries have substantially increased access to treatment and started large scale treatment programmes. Still, low coverage of diagnosis, also due to high cost of diagnostics and lack of optimization of viral hepatitis diagnostic pathway, represents a major barrier towards achieving the global goal of elimination of viral hepatitis as a public health threat by 2030. Given the significant burden of disease due to TB, HIV and viral hepatitis, including co-infections, and low treatment coverage, EECA countries need to ensure early diagnosis and availability of quality assured medicines at affordable prices to expand treatment coverage and prevent the onward transmission of HIV, TB and viral hepatitis. 1 The first Regional Consultation on Expanding Access to Affordable and Quality Assured Antiretroviral and Antituberculosis medicines took place on 2-3 November 2016 in Minsk, Republic of Belarus. The Regional Consultation was hosted by the Ministry of Health of the Republic of Belarus with organizational support of the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Global Fund to Find AIDS, Tuberculosis and Malaria (GFATM), and the Stop TB Partnership. The Consultation brought together Ministers of Health, medicines supply policy makers and regulators of pharmaceutical sector from twelve EECA countries, as well as representatives of international organizations, experts, representatives of pharmaceutical companies and civil society and community activists. The meeting resulted in a joint declaration on expanded and rapidly scaled up access to affordable quality assured ARV and TB medicines in EECA – Minsk Statement of the Ministries of Health of Eastern Europe and Central Asia “HIV and Tuberculosis: Treatment for All”. (Annex 1) To discuss the progress made and challenges in implementation of the Minsk Statement, the follow-up meeting is planned in November 2018 in Minsk, Belarus. Scope and Format The second Regional Consultation planned for 20-22 November 2018 in Minsk is to be hosted by the Ministry of Health of the Republic of Belarus with organizational support by the UNAIDS, GFATM, WHO, and the Stop TB Partnership. The Consultation will get together the Ministers of Health, medicines supply policy makers and regulators of pharmaceutical sector from Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation, Tajikistan, Turkmenistan, Ukraine and Uzbekistan, as well as representatives of international organizations, key partners, relevant experts, representatives of the pharmaceutical companies, procurement agencies and members of civil society. The meeting will consist of two parts – technical consultation to be held from November 20th to November 21st and a high-level meeting planned for November 22nd. The participants of the technical consultation will discuss the progress made and challenges in implementation of Minsk Statement 2016 as well as innovative strategies, actions and opportunities for ensuring long-term access of EECA countries to quality assured medicines and diagnostic technologies for HIV, TB and viral hepatitis at affordable prices and increasingly funded with domestic resources. The high-level meeting will take place under the leadership of the Ministers of Health of the respective countries and with the engagement and support of the UNAIDS, GFATM, WHO Euro and Stop TB Partnership to reach a political agreement and reinstate the commitments made at Minsk meeting in 2016. 2 The main outcome of the Consultation will be signing of the Minsk II Statement on expanded access to affordable and quality assured medicines and diagnostic technologies for HIV, TB and Hepatitis C in Eastern Europe and Central Asia. Objectives of the Regional Consultations 1. To adopt Minsk II Statement on expanded access to affordable and quality assured medicines and diagnostic technologies for HIV, TB and viral hepatitis in EECA 2. To share experiences in HIV, multidrug resistant tuberculosis, Viral Hepatitis prevention and treatment programmes’ implementation at country level including to provide to the countries overview of the current price ranges in medicines and diagnostic technologies for HIV, TB and Viral Hepatitis procured from domestic and international funds in the EECA region 3. To discuss challenges and opportunities in implementation of Minsk I Statement 4. To present and discuss ARV, TB and viral hepatitis medicines and diagnostic market trends and regional demand forecasts from 2018 to 2020 for adult and paediatric patients 5. To agree on policies to promote polyvalent testing platforms in community settings, healthcare facilities, home testing with special attention to cost and cost-effectiveness and the possibility of testing multiple diseases at the same time. 6. To present and discuss opportunities and bottlenecks for the public sector to procure medicines and diagnostics on the international market at low cost (Global Fund Pooled Procurement Mechanism and its online marketplace www.wambo.org, Stop TB partnership GDF, UN agencies, International procurement agents, etc.) 7. To discuss/present instruments allowing accelerated registration of medicines in the countries and achieve commitment to implement it. 8. To discuss the technical assistance required for countries to address existing legal, programmatic and other constraints for procurement of quality assured medicines and diagnostics technologies or for their local manufacture. Expected Participants  Ministers of Health, national experts in HIV, TB and Hepatitis medicines procurement, experts in drug registration and drug market regulation (Belarus, Russian Federation, Kyrgyzstan, Kazakhstan, Armenia, Azerbaijan, Georgia, Republic of Moldova, Tajikistan, Turkmenistan, Uzbekistan, Ukraine, Estonia, Latvia, Lithuania, Poland.  International organizations and partners (WHO, UNDP, UNICEF, UNAIDS, UNITAID, Global Fund, Stop TB Partnership, MSF, MPP, Eurasian Patent Organization, The Partnership for Supply Chain Management (PFSCM) and others. 3  Local, regional and International Civil society organizations (Médecins Sans Frontières (MSF), the International Treatment Preparedness Coalition Russia (ITPCru), “East Europe and Central Asia Union of People Living with HIV” (ECUO), TB Europe Coalition, "AGEP'C" Kazakhstan, Alliance Public Health Ukraine, Eurasian Women's Network on AIDS, and others).  Representatives of the pharmaceutical industry. 4
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel